1. Home
  2. PESI vs MDWD Comparison

PESI vs MDWD Comparison

Compare PESI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PESI
  • MDWD
  • Stock Information
  • Founded
  • PESI 1990
  • MDWD 2000
  • Country
  • PESI United States
  • MDWD Israel
  • Employees
  • PESI N/A
  • MDWD N/A
  • Industry
  • PESI Environmental Services
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • PESI Industrials
  • MDWD Health Care
  • Exchange
  • PESI Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • PESI 153.6M
  • MDWD 179.1M
  • IPO Year
  • PESI 1992
  • MDWD 2014
  • Fundamental
  • Price
  • PESI $11.14
  • MDWD $17.80
  • Analyst Decision
  • PESI Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • PESI 1
  • MDWD 1
  • Target Price
  • PESI $18.00
  • MDWD $28.00
  • AVG Volume (30 Days)
  • PESI 80.7K
  • MDWD 60.7K
  • Earning Date
  • PESI 10-31-2024
  • MDWD 08-14-2024
  • Dividend Yield
  • PESI N/A
  • MDWD N/A
  • EPS Growth
  • PESI N/A
  • MDWD N/A
  • EPS
  • PESI N/A
  • MDWD N/A
  • Revenue
  • PESI $72,199,000.00
  • MDWD $20,141,000.00
  • Revenue This Year
  • PESI N/A
  • MDWD $30.16
  • Revenue Next Year
  • PESI $52.51
  • MDWD $18.44
  • P/E Ratio
  • PESI N/A
  • MDWD N/A
  • Revenue Growth
  • PESI N/A
  • MDWD N/A
  • 52 Week Low
  • PESI $6.51
  • MDWD $7.45
  • 52 Week High
  • PESI $14.17
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • PESI 52.26
  • MDWD 50.02
  • Support Level
  • PESI $9.58
  • MDWD $16.25
  • Resistance Level
  • PESI $10.94
  • MDWD $17.90
  • Average True Range (ATR)
  • PESI 0.50
  • MDWD 0.97
  • MACD
  • PESI 0.04
  • MDWD -0.05
  • Stochastic Oscillator
  • PESI 61.90
  • MDWD 36.98

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: